Abstract A75: Circulating tumor cells in human breast cancer exhibit dynamic changes in epithelial and mesenchymal composition
Min Yu(Howard Hughes Medical Institute), Shyamala Maheswaran(Massachusetts General Hospital), David T. Ting(Massachusetts General Hospital), Kyle Concannon(Harvard University), Jordan C. Ciciliano(Georgia Institute of Technology), Dennis C. Sgroi(Massachusetts General Hospital), Aditya Bardia(UCLA Health), Marissa Wells(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Maria Donaldson Collier(The Netherlands Cancer Institute), Malgorzata E. Smas(Harvard University), Elena F. Brachtel(University of Miami Hospital), Ben S. Wittner(Broad Institute), Shannon L. Stott(Shriners Hospitals for Children - Erie), Lecia V. Sequist(Harvard University), Mehmet Toner(Center for Cancer Research), Ajay M. Shah(University of Wales), Steven J. Isakoff(Harvard University), Sridhar Ramaswamy(Harvard University), José Baselga(Novartis (Switzerland))
Cited by 3
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k